Effect of antifibrinolytic agents and estrogens on blood loss and blood coagulation factors during open heart surgery.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000614:Aminocaproates / Q000494:pharmacology*; D000933:Antifibrinolytic Agents / Q000494:pharmacology; D007611:Aprotinin / Q000494:pharmacology* / Q000627:therapeutic use; D001810:Blood Volume / Q000187:drug effects; D006348:Cardiac Surgical Procedures; D004966:Estrogens, Conjugated (USP) / Q000494:pharmacology* / Q000627:therapeutic use; D005260:Female; D005342:Fibrinolysis / Q000187:drug effects*; D006470:Hemorrhage / Q000517:prevention & control*; D006801:Humans; D008297:Male; D008875:Middle Aged
D000614:Aminocaproates; D000933:Antifibrinolytic Agents; D004966:Estrogens, Conjugated (USP); D007611:Aprotinin